Please use this identifier to cite or link to this item:
|Title:||213Bi-Labeled Prostate-Specific Membrane Antigen-Targeting Agents Induce DNA Double-Strand Breaks in Prostate Cancer Xenografts|
|Authors:||NONNEKENS J; CHATALIC K.l.s.; MOLKENBOER- KUENEN Jannike; BEERENS Cecile; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; VELDHOVEN-ZWEISTRA Joke; SCHOTTELIUS Margret; WESTER Hans-Jürgen; VAN GENT D; VAN WEERDEN W.m.; BOERMAN Otto; DE JONG Marion; HESKAMP Sandra|
|Citation:||CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS vol. 32 no. 2 p. 67-73|
|Publisher:||MARY ANN LIEBERT|
|Type:||Articles in periodicals and books|
|Abstract:||Background: Up to now, prostate-specific membrane antigen (PSMA)-targeted radionuclide therapy mainly focused on b-emitting radionuclides. Herein, two new 213Bi-labeled agents for PSMA-targeted a therapy of prostate cancer (PCa) are reported. Methods: The biodistribution of 213Bi-labeled small-molecule inhibitor PSMA I&T and nanobody JVZ-008 was evaluated in mice bearing PSMA-positive LNCaP xenografts. DNA damage response was followed using LNCaP cells and LNCaP xenografts. Results: In vitro, 213Bi-PSMA I&T and 213Bi-JVZ-008 therapy of LNCaP cells led to increased number of DNA double-strand breaks (DSBs), detected as 53BP1 and cH2AX nuclear foci. In vivo, tumor uptake of 213Bi-PSMA I&T and 213Bi-JVZ-008 was 5.75% – 2.70%ID/g (injected dose per gram) and 2.68% – 0.56%ID/g, respectively, with similar tumor-to-kidney ratios. Furthermore, both agents induced in vivo DSBs in the tumors, which were detected between 1 hour and 24 hours after injection. 213Bi-PSMA I&T induced significantly more DSBs than 213Bi-JVZ-008 ( p < 0.01). Conclusions: 213Bi-PSMA I&T and 213Bi-JVZ-008 showed efficient and rapid tumor targeting and produced DSBs in PSMA-expressing LNCaP cells and xenografts. These promising results require further evaluation of 213Bi-labeled agents with regard to their therapeutic efficacy and toxicity for PCa therapy.|
|JRC Directorate:||Nuclear Safety and Security|
Files in This Item:
There are no files associated with this item.
Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.